We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 162 results
  1. Clinical and genomic features of Mycobacterium avium complex: a multi-national European study

    Background

    The Mycobacterium avium complex (MAC) comprises the most frequent non-tuberculous mycobacteria (NTM) in Central Europe and currently...

    Nils Wetzstein, Margo Diricks, ... Thomas A. Wichelhaus in Genome Medicine
    Article Open access 09 July 2024
  2. Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients

    Background

    Mycobacterium avium complex (MAC) is a group of slow-growing mycobacteria that includes Mycobacterium avium and Mycobacterium intracellulare ...

    Hyun-Eui Park, Kyu-Min Kim, ... Min-Kyoung Shin in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 18 March 2024
  3. Oral vaccination stimulates neutrophil functionality and exerts protection in a Mycobacterium avium subsp. paratuberculosis infection model

    Mycobacterium avium subsp . paratuberculosis (Map) causes paratuberculosis (PTB), a granulomatous enteritis in ruminants that exerts high economic...

    Iraia Ladero-Auñon, Elena Molina, ... Natalia Elguezabal in npj Vaccines
    Article Open access 12 August 2021
  4. Mycobacterium avium: an Emerging Pathogen for Dog Breeds with Hereditary Immunodeficiencies

    Purpose of Review

    Among the non-tuberculous mycobacteria (NTM), Mycobacterium avium complex (MAC) is the leading cause of pulmonary disease in...

    Giovanni Ghielmetti, Urs Giger in Current Clinical Microbiology Reports
    Article Open access 18 August 2020
  5. Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center

    Purpose

    Rapid, reliable identification of mycobacteria from positive cultures is essential for patient management, particularly for the differential...

    Lisa Piasecki, Charlotte Genestet, ... Elisabeth Hodille in European Journal of Clinical Microbiology & Infectious Diseases
    Article 12 April 2024
  6. Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in macrophages

    Mycobacterium avium subsp. paratuberculosis (MAP) causes chronic diarrheic intestinal infections in domestic and wild ruminants (paratuberculosis or...

    Karina M. Cirone, Priyoshi Lahiri, ... Eduardo R. Cobo in Cell and Tissue Research
    Article 02 September 2019
  7. Single Nucleotide Polymorphisms in hsp65 and MACPPE12 Genes of Mycobacterium avium subsp. hominissuis

    Abstract

    Mycobacterium avium subsp. hominissuis ( MAH ) are typical inhabitants of the environment, which are known as opportunistic pathogens of...

    D. A. Starkova, T. Iwamoto, ... O. V. Narvskaya in Russian Journal of Genetics
    Article 01 May 2019
  8. Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease

    The clinical importance of Mycobacterium abscessus subsp. abscessus ( M. abscessus ) lung disease has been increasing, but few studies have assessed...

    Keiji Fujiwara, Koji Furuuchi, ... Kozo Morimoto in European Journal of Clinical Microbiology & Infectious Diseases
    Article 01 September 2020
  9. Avian Tuberculosis

    Avian tuberculosis also known as avian mycobacteriosis is a chronic disease affecting wild and domestic birds including captive and pet birds. The...
    Yashpal Singh Malik, Arockiasamy Arun Prince Milton, ... Souvik Ghosh in Role of Birds in Transmitting Zoonotic Pathogens
    Chapter 2021
  10. Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection

    An 81-year-old immunocompetent patient with bronchiectasis and refractory Mycobacterium abscessus lung disease was treated for 6 months with a...

    Rebekah M. Dedrick, Krista G. Freeman, ... Keira A. Cohen in Nature Medicine
    Article 08 July 2021
  11. Mykobakterielle Erkrankungen

    Katzen können mit einer Vielzahl von schnell und langsam wachsenden Mykobakterienarten infiziert sein, die eine Vielzahl von klinischen Syndromen...
    Carolyn O’Brien in Dermatologie der Katze
    Chapter 2023
  12. Identification of Mycobacterium abscessus species and subspecies using the Cas12a/sgRNA-based nucleic acid detection platform

    The rapidly growing mycobacterium Mycobacterium abscessus is a clinically important organism causing pulmonary and skin diseases. The M. abscessus ...

    Guohui **ao, Su Zhang, ... Guoliang Zhang in European Journal of Clinical Microbiology & Infectious Diseases
    Article 28 November 2019
  13. New Oxazolidinone: Tedizolid

    Tedizolid is a new member of the oxazolidinone class of synthetic antimicrobial developed over 30 years ago. Linezolid is the first member of the...
    Chapter 2023
  14. Emerging and Difficult to Treat Nontuberculous Mycobacteria Infections

    Nontuberculous mycobacteria [NTM] are a large group of environmental organisms [>150 species] that are distributed worldwide, but only a few are...
    Chapter 2020
  15. Microorganisms in Pathogenesis and Management of Ulcerative Colitis (UC)

    With the global rise in incidences of ulcerative colitis and various dysbiosis in the gut microbiota, there has been a growing demand to understand...
    Sanjiv Singh, Punita Aggarwal, ... V. Ravichandiran in Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
    Chapter 2022
  16. Letter J

    Jabs syndrome see Blau syndrome
    Michael R. Shurin, Galina V. Shurin, Ken M. Shurin in Basic and Clinical Immunology by Names
    Chapter 2023
  17. MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus

    Infection with rapidly growing nontuberculous mycobacteria is emerging as a global health issue; however, key host factors remain elusive. Here, we...

    Hyeon Ji Kim, In Soo Kim, ... Eun-Kyeong Jo in Experimental & Molecular Medicine
    Article Open access 20 January 2021
  18. Quorum Sensing and Quorum Sensing Inhibitors of Natural Origin

    Now, infectious bacteria represent the worldwide health threat. Treatment with antimicrobial agents becomes ineffective with the time, especially...
    Nourhan G. Naga, Mona I. Shaaban in Drug Discovery and Design Using Natural Products
    Chapter 2023
  19. Characterization of integrated prophages within diverse species of clinical nontuberculous mycobacteria

    Background

    Nontuberculous mycobacterial (NTM) infections are increasing in prevalence, with current estimates suggesting that over 100,000 people in...

    Cody Glickman, Sara M. Kammlade, ... Michael Strong in Virology Journal
    Article Open access 17 August 2020
  20. Role of Mycobacterium tuberculosis PE and PPE Proteins in Pathogen-Host Interactions

    This article reviews the discovery, structure, secretion, and role in microbial evolution and immuno-pathogenesis of a group of Mycobacterium...
    Govardhan Rathnaiah, Denise K. Zinniel, Raul G. Barletta in Tuberculosis Host-Pathogen Interactions
    Chapter 2019
Did you find what you were looking for? Share feedback.